Cattle Vaccines Market - Type In the cattle vaccines market, the type segment refers to the different categories of vaccines available for use in cattle. This includes live attenuated vaccines, inactivated vaccines, and recombinant vaccines. Live attenuated vaccines contain weakened or modified forms of the virus or bacteria, providing long-lasting immunity with a single dose. Inactivated vaccines use a killed version of the pathogen to stimulate the immune system, often requiring multiple doses to establish immunity. Recombinant vaccines are produced using genetically engineered components to elicit an immune response. Each type of vaccine offers distinct advantages and considerations, impacting their use and market demand. Cattle Vaccines Market - Application The application segment in the cattle vaccines market refers to the specific purposes for which vaccines are used in cattle. This includes vaccines for respiratory diseases, reproductive diseases, clostridial infections, and others. Respiratory disease vaccines target pathogens such as bovine viral diarrhea virus, infectious bovine rhinotracheitis virus, and bovine respiratory syncytial virus, which can cause significant morbidity and mortality in cattle populations. Reproductive disease vaccines aim to prevent conditions such as infectious bovine rhinotracheitis, bovine viral diarrhea, and lepto, which can lead to reproductive failure and economic losses. Clostridial vaccines protect against diseases caused by Clostridium species, which can be fatal in cattle. Each application area requires specific vaccines tailored to the prevalent pathogens and management practices, driving market demand for targeted solutions.